Chronic lower-limb wounds · Comparison study · 2008
Can shockwave help long-standing leg wounds close?
In this study, half of the long-standing leg wounds treated with shockwave closed completely (16 of 32), within 4 to 6 sessions. In a separate group treated with dressings alone, 1 of 10 wounds closed over 8 weeks. Pain eased a little in both groups.
- people with long-standing leg wounds
- 40
- shockwave sessions, 2 weeks apart
- 4–10
- kinds of wound: after injury, vein-related and diabetic
- 3
Good to know: Groups were not assigned at random and were followed for different lengths of time; wounds, not people, were counted.
Saggini R, Figus A, Troccola A, et al. Ultrasound Med Biol, 2008 · Read the paper ↗
How this study worked
The treatment
Shockwave + dressings
Focused
- Pulses
- 100 per area · each cm² of wound
- Strength
- 0.037mJ/mm² · 4 per second
- Numbing
- None
- Device
- Evotron/Trode
- Everyone also got
- Their usual dressings and pain medicines, unchanged
Compared with: Regular dressings alone, in a separate group of 10 people
Settings are what each study used, not a prescription.
Who took part
40 people with long-standing leg wounds after injury, from vein problems or from diabetes: 30 had shockwave (32 wounds) and 10 dressings only.
Side effects
Eight people felt a brief, slight rise in pain during some sessions. No bleeding or bruising was reported. One wound that would not heal turned out to have a bone infection and needed surgery.
All the numbers and the full appraisal
The results, in numbers.
30 ESWT patients with 32 wounds and 10 dressing-control patients with 10 wounds; traumatic, venous and diabetic etiologies.
Participant counts; outcome-specific denominators remain in each panel.
Participant counts; outcome-specific denominators remain in each panel.
Complete wound closure1 reported outcome
Complete wound closure
Complete wound closure wounds
Complete closure: 16/32 ESWT wounds versus 1/10 control wounds. Denominators are wounds, not participants; unequal assessment windows and nonrandomized allocation.
Analysis details and source
Complete closure: 16/32 ESWT wounds versus 1/10 control wounds. Denominators are wounds, not participants; unequal assessment windows and nonrandomized allocation.
Numeric box pain score1 reported outcome
Numeric box pain score
Numeric box pain score points, 0–10
| Group | n | Baseline | Follow-up |
|---|---|---|---|
| Shockwave treatment | — | — | 5.03 |
| Control | — | — | 5.5 |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Baseline 6.65 and 6.2; reported ESWT within-group p<.001 is not a treatment contrast; table rows may repeat bilateral patients. The Results also report a Wilcoxon matched-pairs test applied to the differences between the two groups (p < 0.01, one value given jointly for wound area, granulation tissue and pain); the paper does not explain how two unpaired groups of unequal size were matched.
Analysis details and source
Baseline 6.65 and 6.2; reported ESWT within-group p<.001 is not a treatment contrast; table rows may repeat bilateral patients. The Results also report a Wilcoxon matched-pairs test applied to the differences between the two groups (p < 0.01, one value given jointly for wound area, granulation tissue and pain); the paper does not explain how two unpaired groups of unequal size were matched.
Wound area and wound-bed changes1 reported outcome
Wound area and wound-bed changes
Wound area and wound-bed changes wounds and percentage area change
Among unhealed treated wounds, mean area reduction was 37.5% (22–60%) for traumatic wounds, 45% (32–70%) for venous wounds and 50% for diabetic wounds. Granulation and exudate improved (reported p<.01); control baseline-to-eight-week changes were nonsignificant. Closure by cause was 11/16 traumatic, four venous and 1/4 diabetic wounds. The venous denominator is inconsistent (11 versus 12) in the source; no corrected percentage is inferred.
Analysis details and source
Among unhealed treated wounds, mean area reduction was 37.5% (22–60%) for traumatic wounds, 45% (32–70%) for venous wounds and 50% for diabetic wounds. Granulation and exudate improved (reported p<.01); control baseline-to-eight-week changes were nonsignificant. Closure by cause was 11/16 traumatic, four venous and 1/4 diabetic wounds. The venous denominator is inconsistent (11 versus 12) in the source; no corrected percentage is inferred.
How treatment was delivered
Evotron with hand-held Trode probes (focal volume 10–15 mm in diameter); 100 impulses/cm², 0.037 mJ/mm², 4 Hz, 4–10 sessions every 2 weeks; no anesthesia. Gauze/gel contact; prior dressings and stable analgesics continued.
Eight treated patients reported transient one-point pain increases during some sessions; six reported no pain improvement after treatment. No bleeding, petechiae, hematoma or seroma reported. One resistant wound proved to have osteomyelitis requiring surgery.
Unclear allocation, unequal follow-up and different etiologies prevent a causal estimate. Wounds outnumber patients; no clustering correction described. Text alternates 11/12 venous ulcers and tables contain dimension/area discrepancies. No formal economic evaluation supports cost-effectiveness wording; no explicit conflict statement located.
Findings checked against the full source by a separate automated reviewer.
Limitations noted by the reviewers
- Unclear allocation, unequal follow-up and different etiologies prevent a causal estimate. Wounds outnumber patients; no clustering correction described. Text alternates 11/12 venous ulcers and tables contain dimension/area discrepancies. No formal economic evaluation supports cost-effectiveness wording; no explicit conflict statement located.
Source-linked critical reading
Nonrandomized comparisons
Technical source record
Full source read: body, methods, results, all tables and figure captions, discussion and references; the article prints no disclosures section and refers to no supplementary material.
Some stubborn wounds closed, especially traumatic wounds, but this comparison cannot tell how much benefit came from shockwaves.
How do chronic wound closure and pain after shockwave treatment compare with dressing care in this nonrandomized cohort?
Nonrandomized comparative study of 30 treated patients with 32 wounds and 10 control patients with 10 wounds, with unequal observation windows.
30 ESWT patients with 32 wounds and 10 dressing-control patients with 10 wounds; traumatic, venous and diabetic etiologies.
Focused ESWT every two weeks, 4–10 sessions, with prior wound care continued.
Ten separately recruited controls received regular dressings for 8 weeks; random treatment allocation is not established.
The extracted panels retain the original outcome units and assessment times. 16/32 treated wounds closed, versus 1/10 controls at 8 weeks. Treated wounds closed within 4–6 sessions; additional sessions up to 10 gave little further benefit. Pain fell from 6.65 to 5.03, versus 6.2 to 5.5 in controls.
16/32 treated wounds closed, versus 1/10 controls at 8 weeks. Treated wounds closed within 4–6 sessions; additional sessions up to 10 gave little further benefit. Pain fell from 6.65 to 5.03, versus 6.2 to 5.5 in controls.
Eight treated patients reported transient one-point pain increases during some sessions; six reported no pain improvement after treatment. No bleeding, petechiae, hematoma or seroma reported. One resistant wound proved to have osteomyelitis requiring surgery.
Unclear allocation, unequal follow-up and different etiologies prevent a causal estimate. Wounds outnumber patients; no clustering correction described. Text alternates 11/12 venous ulcers and tables contain dimension/area discrepancies. No formal economic evaluation supports cost-effectiveness wording; no explicit conflict statement located.
Suggests feasibility after failed dressings, but posttraumatic, venous and diabetic wounds should not be combined into a universal success probability.
Randomize patients to identical wound care with active or sham treatment, use common assessment times and account for multiple wounds per patient while separating wound etiologies.
Read the original article.
Extracorporeal Shock Wave Therapy for Management of Chronic Ulcers in the Lower Extremities
Saggini R, Figus A, Troccola A, Cocco V, Saggini A, Scuderi N. · Ultrasound Med Biol · 2008
Open the publication record or available full-text files.
Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →